Testing effectiveness (Phase 2)Study completedNCT00003466
What this trial is testing
Temozolomide in Treating Patients With Progressive Low-Grade Glioma
Who this might be right for
Brain and Central Nervous System Tumors
Duke University 100
Showing 8 of 8 results